Clinigen Group Plc (CLIGF) Given Average Rating of “Strong Buy” by Analysts

Clinigen Group Plc (NASDAQ:CLIGF) has been assigned an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.

Zacks has also assigned Clinigen Group Plc an industry rank of 117 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research downgraded shares of Clinigen Group Plc from a “buy” rating to a “hold” rating in a report on Tuesday, August 29th.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://sportsperspectives.com/2017/11/02/clinigen-group-plc-cligf-given-average-rating-of-strong-buy-by-analysts.html.

Get a free copy of the Zacks research report on Clinigen Group Plc (CLIGF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Clinigen Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply